- Foxglove, a self-proclaimed tech justice nonprofit, launched the ‘No Palantir in Our NHS’ campaign to oppose the data analytics company Palantir Technologies Inc (NYSE: PLTR) collaboration with the UK’s National Health Service (NHS), CNBC reports.
- The campaign was supported by more than 50 other organizations working on civil liberties, anti-racism, migrant justice and public health.
- Palantir’s partnership with the NHS aimed to help the government and health services use the data to monitor the spread of the pandemic.
- The NHS COVID-19 Data Store contract allowed Palantir to help manage the data lake that held everyone’s health data for pandemic purposes.
- In March 2020, the contract was sold as part of a short-term effort to predict how best to deploy resources to deal with the pandemic. However, the contract was quietly extended in December when the NHS and Palantir signed a two-year £ 23million ($ 34million) deal.
- Palantir processes patient data while the NHS remains the owner of the data, limiting Palantir’s activities.
- Facebook Inc (NASDAQ: FB) Peter Thiel, board member and co-founder of Palantir, is said to have donated $ 1.25 million for Donald Trump’s presidential campaign.
- Palantir had also faced criticism for supporting spy agencies, border forces and the military. It has been linked to the search for undocumented Americans with the development of unmanned drones for bombing and intelligence.
- Palantir has tried to expand its European business in recent years and has a significant presence in London’s Soho district.
- The company did not win any contracts by lobbying the UK Department of Commerce and health officials in 2019.
- The Financial Times reported on Palantir’s recent acquisition of a stake in British healthcare firm Babylon in a $ 4.2 billion blank check deal.
- Price action: PLTR shares closed up 1.69% at $ 24.03 on Friday.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.